Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission
Johan Burisch, Mirabella Zhao, Selwyn Odes, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 5, pp. 458-492
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Ulcerative colitis
Catherine Le Berre, Sailish Honap, Laurent Peyrin‐Biroulet
The Lancet (2023) Vol. 402, Iss. 10401, pp. 571-584
Closed Access | Times Cited: 503
Forecasting the Incidence and Prevalence of Inflammatory Bowel Disease: A Canadian Nationwide Analysis
Stephanie Coward, Eric I. Benchimol, Çharles N. Bernstein, et al.
The American Journal of Gastroenterology (2024) Vol. 119, Iss. 8, pp. 1563-1570
Open Access | Times Cited: 18
AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn’s Disease
Ashwin N. Ananthakrishnan, Jeremy Adler, Karen A. Chachu, et al.
Gastroenterology (2023) Vol. 165, Iss. 6, pp. 1367-1399
Open Access | Times Cited: 25
Review article: Measuring disease severity in inflammatory bowel disease – Beyond treat to target
Akhilesh Swaminathan, Andrew S. Day, Miles Sparrow, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 9, pp. 1176-1199
Open Access | Times Cited: 10
Physical Activity is Associated with a Decreased Risk of Developing Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Ho Tuan Tiong, Dali Fan, Chris Frampton, et al.
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. 9, pp. 1476-1485
Closed Access | Times Cited: 7
Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review
Elham Zarenezhad, Hussein T. Abdulabbas, Ahmed Shayaa Kareem, et al.
Archives of Microbiology (2023) Vol. 205, Iss. 6
Open Access | Times Cited: 19
Berberine alleviates inflammation and suppresses PLA2-COX-2-PGE2-EP2 pathway through targeting gut microbiota in DSS-induced ulcerative colitis
Hansheng Yu, Shaobao Zhang, Ruiming Li, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 695, pp. 149411-149411
Closed Access | Times Cited: 16
Impact of HLA-DQA1*05 Genotype in Immunogenicity and Failure to Treatment with Tumour Necrosis Factor-alpha Antagonists in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Leticia Rodríguez-Alcolado, Elena Grueso-Navarro, Ángel Arias, et al.
Journal of Crohn s and Colitis (2024) Vol. 18, Iss. 7, pp. 1034-1052
Closed Access | Times Cited: 6
The Cost of Inflammatory Bowel Disease Care – How to Make it Sustainable
Johan Burisch, Jennifer Claytor, Inmaculada Hernandez, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 23, Iss. 3, pp. 386-395
Open Access | Times Cited: 6
Association of TMAO levels with indicators of ulcerative colitis activity.
Yelena Laryushina, Nadezhda Samoilova-Bedych, Lyudmila Turgunova, et al.
PubMed (2025) Vol. 16, Iss. 1, pp. 114-125
Closed Access
Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand, 2018–2023
Angela Forbes, Andrew S. Day, Chris Frampton, et al.
Digestive Diseases and Sciences (2025)
Closed Access
Metabolite Profiling in Assessing Ulcerative Colitis Activity: A Systematic Review
Deliang Cui, Xu Han, J. H. Jin, et al.
Human Nutrition & Metabolism (2025), pp. 200298-200298
Open Access
Proteomic Profiling of Extracellular Vesicles in Inflammatory Bowel Diseases
Montserrat Baldán‐Martín, Mikel Azkargorta, Ainhoa Lapitz, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 526-526
Open Access
Oral Akkermansia muciniphila Biomimetic Nanotherapeutics for Ulcerative Colitis Targeted Treatment by Repairing Intestinal Epithelial Barrier and Restoring Redox Homeostasis
Qiqi Zhang, Peng Li, Qian Zhang, et al.
ACS Applied Materials & Interfaces (2025)
Closed Access
Fermented pea yoghurt mitigates DSS induced ulcerative colitis through gut microbiota modulation and enhanced SCFA production in a mouse model
Mengdi Zhao, Yuanyuan Zhang, Yi Wu, et al.
Food Bioscience (2025) Vol. 65, pp. 106046-106046
Open Access
An abundant ginger compound furanodienone alleviates gut inflammation via the xenobiotic nuclear receptor PXR in mice
Xiaojuan Wang, Guohui Zhang, Zhiwei Bian, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Understanding the Learning Curve of Intestinal Ultrasound in Inflammatory Bowel Disease: A Comparative Study Between Novice, Regular and Expert
Léo Bove, Jérémy Meyer, Michael Collins, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102548-102548
Open Access
Effects of psychological stress on inflammatory bowel disease via affecting the microbiota–gut–brain axis
Yuhan Chen, Xiaofeng Chen, Sheng‐Hao Lin, et al.
Chinese Medical Journal (2025)
Open Access
Genetic Variation in Targets of Antihyperglycemic Drugs and Inflammatory Bowel Disease’ Risk: A Mendelian Randomization Study
Jiaxi Zhao, Rong Chen, Mengqi Luo, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2025) Vol. 19, Iss. 3, pp. 103204-103204
Closed Access
Paradigm Shift in Inflammatory Bowel Disease Management: Precision Medicine, Artificial Intelligence, and Emerging Therapies
Antonio M. Caballero‐Mateos, Guillermo A. Cañadas‐De la Fuente, Beatriz Gros
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1536-1536
Open Access
Multi-functionalized probiotics through layer-by-layer coating with tannic acid-Mg2+ and casein phosphopeptide complexes for preventing ulcerative colitis
Zhanyin Qian, Zihan Zhai, M Ren, et al.
Materials Today Bio (2025), pp. 101621-101621
Open Access
MR2938 relieves DSS-induced colitis in mice through inhibiting NF-κB signaling and improving epithelial barrier
Ling Lv, Mireguli Maimaitiming, Shuli Xia, et al.
Marine Life Science & Technology (2025)
Open Access
PPAR-Gamma Orchestrates EMT, AGE, and Cellular Senescence Pathways in Colonic Epithelium and Restrains the Progression of IBDs
Simona Pompili, Antonella Vetuschi, Giovanni Latella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8952-8952
Open Access | Times Cited: 14
Atopic Dermatitis in Early Childhood and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study
Tereza Lerchová, Ketil Størdal, Björn Andersson, et al.
The Journal of Pediatrics (2024) Vol. 270, pp. 114027-114027
Open Access | Times Cited: 4
Zhilining Formula alleviates DSS-induced colitis through suppressing inflammation and gut barrier dysfunction via the AHR/NF-κBp65 axis
Rui Zhou, Kaiwen Huang, Simin Chen, et al.
Phytomedicine (2024) Vol. 129, pp. 155571-155571
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top